Brief: Neovacs H1 Net Loss Narrows to 6.1 Million Euros
30/10/2018 17:23
Oct 30 (Reuters) - NEOVACS SA ALNEV.PA :
* H1 NET LOSS EUR 6.1 MILLION VERSUS LOSS OF EUR 8.1
MILLION YEAR
AGO
* 2019 DEVELOPMENT PLAN CONFIRMED
* H1 OPERATING LOSS EUR 6.6 MILLION VERSUS LOSS OF EUR 10.2
MILLION YEAR AGO
* CASH POSITION OF EUR 4.7M AS AT JUNE 30, 2018
* H1 REVENUE EUR 19,000 VERSUS EUR 0.5 MILLION YEAR AGO
Source text for Eikon: ID:nGNELSh7W
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants